Market Research Future

Future Scope of "Kidney Stone Market" Orientation by Type, Leading Player and Forecast to 2023

Kidney Stones Market Information, by types (calcium, uric acid, struvite and cystine), by diagnostic tests (CT scan, X-rays, ultrasound scan, intravenous urogram)- Forecast till 2023


Pune, India -- (SBWIRE) -- 03/29/2018 -- The Global Kidney Stone Market is expected to grow at a CAGR of 4.0% during the forecast period and is estimated to reach USD 3,000 million by 2023.

Kidney stones are mineral material which are intense and crystalline molded in the kidney and urinary tract. Medicinal expression for kidney stones is nephrolithiasis. in accordance with countrywide wellbeing administration (NHS), kidney stones generally impacts people in the age assortment from 30 to 60.kidney stones is initiated because of various factors, for example, lack of hydration, beyond any doubt eats less which are unnecessary in sugar protein, salt, weight and distinctive clinical circumstances like constructive meds, cystinuria, hyperparathyroidism, renal tubular acidosis and some urinary tract diseases.

Kidney stones commercial center is likely to grow a stimulating blast because of different reasons comprehensive of upward push in developing old populace, creating rate in diabetes, hypertension and radical utilization of acid neutralizers, protein and carbonated containing fluids. In addition, components, for example, creating masses and bringing nourishment is conceivably down to improve the overall kidney stones commercial center in developing countries.

The restrictions are absence of learning among individuals. These variables are plausible to decrease the development of kidney stones market.

Key Market Players:

There are various market players operating in the Global Kidney Stones Market. Market players are Olympus Corporation, Boston Scientific Corporation, Convergent Laser Technologies, DirexGroup, Siemens Healthcare GmbH, C.R. Bard Inc, Cook Medical Inc., Dornier MedTech GmbH, Richard Wolf Medical Instruments Corporation, and Stryker Corporation

Get a Sample Copy of This Report @ .

Boston Scientific Corporation

Founded on 1979, Boston Scientific Corporation is engaged in the manufacturing and development of various medical devices. The firm offers products in three segments, Cardiovascular, Rhythm Management, and MedSurg. The firm offers various products such as thrombectomy systems, stents, chambers, ultrasound catheters, diagnostic catheters, delivery sheaths, the firm also offers products to treat diseases of the gastrointestinal and pulmonary conditions. The firm has focused on various organic and inorganic growth strategies to enhance its product portfolio and increase its customer base. For instance in the year, 2016, Boston Scientific Corporation launched Dakota Nitinol Stone Retrieval Device in collaboration with OpenSure Handle at the 34th World Congress of Endourology conference in South Africa. This device aims to reduce the hassles that occur during ureteroscopy procedures. This product launch aims to enhance its customer base and its geographic presence.


Incorporated on 1991, and headquartered at Israel, Lumenis Ltd. is one of the leading healthcare provider for minimally invasive procedures. Lumenis Ltd offers products in three segments, Ophthalmic Surgical, and Aesthetic. End users of the firm are urology and genitourinary, hospitals, outpatient clinics, ambulatory surgery centres, and medical practices. The firm has focused on growth strategies such as product launches, collaborations and acquisitions to enhance its product portfolio and its geographic presence.

Get Attractive Discount on This Report @ .

For instance in 2017, the firm launched Moses holmium technology. Moses holmium technology is designed to reduce retropulsion during the surgery which helps in less stone migration and a more efficient procedure. This product launch aims to enhance the firm's customer base and increase its already existing wide product portfolio.

Regional Analysis:

The global kidney stone market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the market, particularly, North America due to rising prevalence of renal diseases in this region. Additionally, continuous innovation in the treatment methods and the presence of the global market leaders contribute to the market growth.

In the Europe, availability innovative healthcare solutions for diagnostics, availability of funds for research & development activities, and increasing adoption of new treatment methods are responsible for the growth of the market.

Asia Pacific is the fastest growing and potential kidney stone market whose growth is attributed to the rising geriatric population with kidney related problems, government focus on research and development in healthcare sector.

The Middle East & Africa is expected witness limited growth due to limited access to the healthcare resources and lack of advanced treatment methods.

Inquire about This Report @ .


About Market Research Future:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.